Interval cancers as an indicator of perfomance in breast screening

Breast Cancer

Volumn 7, Issue 1, 2000, Pages 9-18

  Warren, Ruth ^a,c   Duffy, Stephen ^b  

^a Epping Breast Screening Service   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Interval cancers; Mammography; Screening performance

Indexed keywords

ARTICLE; BREAST TUMOR; EVALUATION; FEMALE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; LEGAL ASPECT; MALPRACTICE; MAMMOGRAPHY; MANPOWER; MASS SCREENING; NATIONAL HEALTH SERVICE; PAGET NIPPLE DISEASE; PREVALENCE; RADIOGRAPHY; RADIOLOGY; STATISTICS; TIME; UNITED KINGDOM;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FALSE NEGATIVE REACTIONS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALPRACTICE; MAMMOGRAPHY; MASS SCREENING; PREVALENCE; PROGRAM EVALUATION; RADIOLOGY; STATE MEDICINE; TIME FACTORS;

EID: 0033655277     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967182     Document Type: Article

References (70)

1. Day N, Williams D, Khaw K: Breast cancer screening programmes; The development of a monitoring and evaluation system. Br J Cancer 59:954-958, 1989. (Pubitemid 19155717)
2. Asbury D, Boggis CR, Sheals D, et al: NHS breast screening programme; Is the high incidence of interval cancers inevitable? BMJ 313:1369-1370, 1996. (Pubitemid 26400125)
3. Day N, McCann J, Camilleri-Ferrante C, et al: Monitoring interval cancers in breast screening programmes; The East Anglian experience. J Med Screening 2:180-185, 1995.
4. Moss S, Coleman D, Ellman R, et al: Interval cancers and sensitivity in the screening centres of the UK Trial of Early Detection of Breast Cancer. Eur J Cancer 29:255-258, 1993.
5. Kee F, Gorman D, Odling-Smith W: Confidence intervals and interval cancers; Needles and haystacks. Public Health 106:29-35, 1992.
6. Brekelmans C, Colette H, Colette C, et al: Breast cancer after a negative screen; Follow-up of women participating in the DOM screening programme. Eur J Cancer 28:893-895, 1992.
7. Peeters P, Verbeek A, Hendriks J, et al: The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59:929-932, 1989. (Pubitemid 19155710)
8. Faux A, Richardson D, Lawrence G, et al: Interval breast cancers in the NHS breast screening programme; Does the current definition exclude too many? J Med Screening 4:169-173, 1997. (Pubitemid 28270258)
9. Woodman C, Threlfall A, Boggis C, et al: Is the three year breast screening interval too long?; Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310:224-226, 1995.
10. Duncan A, Wallis M: Classifying interval cancers. Clin Radiol50:774-777, 1995.
11. Simpson W, Neilson F, Young J, et al: The identification of false negatives in a population of interval cancers; A method for audit of screening mammography. The Breast 4:183-188, 1995.
12. Field S, Michell M, Wallis M, et al: What should be done about interval breast cancers? BMJ 310:203-204, 1995.
13. Burhenne H, Burhenne L, Goldberg F, et al: Interval cancers in the screening programme of British Columbia; Analysis & classification. AJR 162:1067-1071, 1994. (Pubitemid 2070674)
14. Moskowitz M: Interval cancers and screening for breast cancer in British Columbia. AJR 162:1072-1075, 1994. (Pubitemid 2070676)
15. Moseson D, Meharg I Tumor registry audit of mammography in community practice. Am J Surg 167:505-508, 1993. (Pubitemid 24203534)
16. Reintgen D, Berman C, Cox C, et al: The anatomy of missed breast cancers. Surg Oncol 2:65-75, 1993. (Pubitemid 23098884)
17. van Dijk J, Verbeek A, Hendriks J, et al: The current detectability of breast cancer in a mammographic screening programme; A review of the previous mammograms of interval and screen detected cancers. Cancer 72:1933-1938, 1993. (Pubitemid 23262123)
18. Bird R, Wallace T, Yankaskas B: Analysis of cancers missed at screening mammography. Radiology 184:613-617, 1992.
19. Andersson I: What can we learn from interval cancers? Recent Results of Cancer Research 90:161-163, 1984.
20. Martin J, Moskowitz M, Milbrath J: Breast cancer missed by mammography. AJR 132:737-739, 1979. (Pubitemid 9174593)
21. Vitak B: Invasive interval cancers in the Ostergotland mammographic screening programme; Radiological analysis. Eur Radiol 8:639-646, 1998. (Pubitemid 128546289)
22. Burrell H, Sibbering D, Wilson A, et al: Screening interval breast cancers; Mammographic features and prognostic factors. Radiology 199:811-817, 1996. (Pubitemid 26157489)
23. Johnson A, Shekhdar J: Interval cancers in the National Health Service Breast Screening Programme. Br J Radiol68:862-869, 1995.
24. Brekelmans C, Peeters P, Deurenberg J, et al: Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 31:1830-1835, 1995.
25. Ciatto S, Roselli del Turco M, Bonardi R, et al: Mammographic screening; An analysis of the characteristics of interval carcinomas observed in the programme in the province of Firenze (1989-91) [ItalianJ. Radiologia Medica 87:412-416, 1994.
26. Brekelmans C, Peeters P, Faber J, et al: The epidemiological profile of women with an interval cancer in the DOM programme. Breast Cancer Res Treat 30:223-232, 1994. (Pubitemid 24262117)
27. Hollingsworth A, Taylor L, Rhodes D: Establishing a histologic basis for false negative mammograms. Am J Surg 166:643-647, 1993. (Pubitemid 24309337)
28. Senie R, Lesser M, Kinne D, et al: Method of tumor detection influences disease-free survival of women with breast carcinoma. Cancer 73:1666-1672, 1993. (Pubitemid 24085267)
29. Klemi P, Joensuu H, Toikkanen S, et al: Aggressiveness of breast cancers found with and without screening. BMJ 304:467-469, 1992.
30. Frisell J, yon Rosen A, Wiege M, et al: Interval cancer and survival in a randomised breast cancer screening trial in Stockholm. Breast Cancer Res Treat 24:11-16, 1992. (Pubitemid 23012688)
31. von Rosen A, Frisell J, Nilsson R, et al: Histopathological and cytochemical characteristics of interval breast carcinomas from the Stockholm mammography screening project. Acta Oncol 31:399-402, 1992.
32. Ikeda D, Andersson I, Watsgard C, et al: Interval cancers in the Malmo mammographic screening trial; Radiographic appearance and prognostic considerations. AJR 159:287-294, 1992.
33. Yoshida K, Abe R, Itoh S, et al: Comparison of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan. Jpn J Clin Oncol20:374-379, 1990.
34. Holmberg L, Tabar L, Adami H, et al: Survival in breast cancer diagnosed between screening examinations. Lancet ii:27-28, 1986.
35. yon Rosen A, Erhardt FL Hellstrom L, et al: Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat 6:221-227, 1985. (Pubitemid 16203155)
36. deGroote R Jr, Milazzo J, Warden M, et al: Interval breast cancer; A more aggressive subset of breast neoplasias. Surgery 94: 543-547, 1983. (Pubitemid 13012174)
37. Holland R, Mravunac M, Hendriks J, et al: So-called interval cancers of the breast. Cancer 49:252-2533, 1982.
38. Tabar L, Fagerberg G, Chen H, et al: Screening for breast cancer in women aged under 50; Mode of detection, incidence, fatality and histology. J Med Screening 2:94-98, 1995.
39. Vitak B, Olsen K, Manson J, et al: Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening; A comparison of true interval and missed interval cancers. Eur Radiol 9:460-469, 1999.
40. Wolverton D, Sickles E: Clinical outcome of doubtful mammographic findings. AJR 167:1041-1045, 1996. (Pubitemid 26322272)
41. Brenner R: Medicolegal aspects of breast imaging. Radiol Clin North Am 30:277-286, 1992.
42. Brenner RJ: Mammography and malpractice litigation; Current status, lessons, and admonitions. AJR 161:931-935, 1993. (Pubitemid 23333145)
43. Maes R, Dronkers D, Hendriks J, et al: Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment? Br J Radiol70:34-38, 1997. (Pubitemid 27077554)
44. Forrest A: Breast Cancer Screening, HMSO, LONDON, 1986.
45. Brown J, Bryan S, Warren R: Mammography screening; An incremental cost effectiveness analysis of double versus single reading of mammograms. BMJ 312:809-812, 1996. (Pubitemid 26099299)
46. Bryan S, Brown J, Warren R: Mammography screening; An incremental cost effectiveness analysis of two versus one view procedures in London. J Epidemiol Community Health 49:70-78, 1995.
47. Warren R, Duffy S: Comparison of single reading with double reading of mammograms and change in effectiveness with experience. Br J Radiol 68:958-962, 1995.
48. Warren IL Dully S, Bashir S: The value of the second view in screening mammography. Br J Radiol 69:105-108, 1996. (Pubitemid 26067449)
49. Warren R: Costs and benefits in screening mammography; Choices that may affect outcomes [MDJ. Cambridge, 1995.
50. Warren R, Duffy S: A comparison of the effectiveness of 28kV (grid) versus 25kV (no grid) mammographic technique for breast screening. Br J Radiol 70:1022-1027, 1997. (Pubitemid 27464203)
51. Young KC, Wallis MG, Ramsdale ML: Mammographic film density and detection of small breast cancers. Clin Radiol49:461-465, 1994. (Pubitemid 24229499)
52. Tabar L, Fagerberg G, Day N, et al: Breast cancer treatment and natural history; New insights from results of screening. Lancet 339:412-414, 1992.
53. Grontoft O: Staging and grading of invasive ductal carcinoma in a randomised population screened by mammography. In: Day N, Miller A eds, Screening for Breast Cancer, Hans Huber, Bern pp 75-82, 1988.
54. Bloom H, Richardson W: Histological grading and prognosis in breast cancer. Br J Cancer 11:359, 1957.
55. Tabar L, Fagerberg G, Duffy SW, et al: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187-210, 1992.
56. Ong G, Austoker J, Brett J: Breast screening; Adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty; A mulficentre study. J Med Screening 4:158-168, 1997. (Pubitemid 28270257)
57. Warren R: Team learning and breast cancer screening (letter). Lancet 338:514, 1991.
58. Warren R: Breast screening applies for BS5750/ ISO9002. Br J Radiol65:84, 1992.
59. Brown J, Bryan S, Warren R: Consensus double reading of mammograms was more effective and less cosily than single reading. Evidence-based Medicine November/December:224, 1996.
60. Pattnick J, Muir Gray J: Guidelines in the Collection and Use of Breast Cancer Data, NHSBSP, Report No.26, January 1993, Sheffield, 1993.
61. Tabar L, Dean P: Teaching Atlas of Mammography, 2nd ed, Georg Thieme Verlag, Stuttgart, New York, 1985.
62. Harvey JA, Fajardo LL, Innis CA: Previous mammograms in patients with impalpable breast carcinoma; Retrospective vs blinded interpretation; 1993 ARRS President's Award. AJR 161:1167-1172, 1993. (Pubitemid 24008056)
63. Warren R: Doctor managers and their performance as doctors (letter). Lancet 343:1641, 1994. (Pubitemid 24194829)
64. RCR: Medical Staffing and Workload in Clinical Radiology in the United Kingdom National Health Service, The Royal College of Radiologists, London, 1993.
65. Warren R: The debate over mass mammography in Britain; The case for. BMJ 297:969-970, 1988.
66. Mackworth J: Vigilance and Attention; A Signal Detection Approach, Penguin, Harmondsworth 1970.
67. Nawano S, Murakami K, Moriyama N, et al: Computer-aided diagnosis in full digital mammography. Invest Radiol34:310-316, 1999. (Pubitemid 29157707)
68. Jiang Y, Nishikawa R, Schmidt R, et al: Improving breast cancer diagnosis with computer-aided diagnosis. Acad Radiol 6:22-33, 1999. (Pubitemid 29061477)
69. Austin R, McLendon W: The Papanicolau smear; Medicine's most successful cancer screening procedure is threatened. J AmA 277:754-75, 1997.
70. Potchen EJ, Bisesi MA, Sierra AE, et al: Mammography and malpractice. AJR 156:475-480, 1991.